Core Insights - CBOE Global reported revenue of $565.2 million for Q1 2025, a 12.6% year-over-year increase, with EPS of $2.50 compared to $2.15 a year ago, exceeding Zacks Consensus Estimates [1] - The company achieved a revenue surprise of +1.54% and an EPS surprise of +5.93% compared to analyst expectations [1] Financial Performance Metrics - Average Revenue Per Contract for Futures was $1.74, slightly below the $1.76 estimate [4] - Average Daily Volume for Multi-listed options was 13.41 million, exceeding the 12.99 million estimate [4] - Access and capacity fees generated $97.80 million, surpassing the $96.55 million estimate, reflecting an 8.6% year-over-year increase [4] - Market data fees totaled $77.80 million, above the $75.92 million estimate, with an 8.1% year-over-year increase [4] - Other revenue was $25 million, below the $28.23 million estimate, representing a -5.3% change year-over-year [4] - Net transaction and clearing fees reached $832.60 million, exceeding the $788.83 million estimate, with a 15.9% year-over-year increase [4] - Regulatory fees surged to $161.80 million, significantly above the $90.18 million estimate, marking a 222.3% year-over-year increase [4] Stock Performance - CBOE shares returned -2% over the past month, compared to a -0.5% change in the Zacks S&P 500 composite [3] - The stock currently holds a Zacks Rank 2 (Buy), indicating potential outperformance in the near term [3]

Core Insights - Wall Street analysts expect Zoetis (ZTS) to report quarterly earnings of $1.40 per share, reflecting a year-over-year increase of 1.5% [1] - Revenues are anticipated to be $2.19 billion, unchanged from the same quarter last year [1] - The consensus EPS estimate has been revised 0.2% lower over the last 30 days, indicating a reevaluation of initial estimates by analysts [1] Revenue Estimates - 'Revenues- Contract Manufacturing & Human Health' are projected to reach $19.16 million, a decrease of 4.2% from the prior-year quarter [4] - 'Revenues- Companion Animal' are expected to be $1.54 billion, showing an increase of 6.3% year over year [4] - 'Revenues- Livestock' are estimated at $631.41 million, indicating a decline of 12.3% compared to the previous year [4] Livestock Revenue Breakdown - 'Revenues- Livestock - Cattle' are forecasted at $324.74 million, reflecting a decrease of 17% from the prior-year quarter [5] - 'Revenues- Livestock - Swine' are expected to reach $128.40 million, suggesting a slight increase of 1.1% year over year [5] - 'Revenues- Livestock - Poultry' are projected to be $142.19 million, indicating a year-over-year increase of 2.3% [5] Geographic Revenue Estimates - 'Geographic Revenues- U.S.' are estimated at $1.19 billion, reflecting a year-over-year increase of 2% [6] - 'Geographic Revenues- International Revenue' are expected to be $987.35 million, indicating a decrease of 2% year over year [6] - 'Geographic Revenues- International - Livestock' are projected at $402.51 million, reflecting a decline of 11.5% from the prior-year quarter [6] Companion Animal Revenue Insights - 'Geographic Revenues- International - Companion Animal' are expected to reach $587.13 million, indicating a year-over-year increase of 6.4% [7] - 'Geographic Revenues- U.S.- Livestock' are projected at $225.66 million, suggesting a decrease of 14.8% year over year [7] - 'Geographic Revenues- U.S.- Companion Animal' are estimated at $955.61 million, reflecting a year-over-year increase of 6.4% [8] Stock Performance - Shares of Zoetis have decreased by 4.3% in the past month, compared to a 0.7% decline in the Zacks S&P 500 composite [8] - With a Zacks Rank 3 (Hold), Zoetis is expected to mirror the overall market performance in the near future [8]

Core Viewpoint - Analysts forecast Exxon Mobil (XOM) will report quarterly earnings of $1.72 per share, reflecting a year-over-year decline of 16.5%, with anticipated revenues of $84.49 billion, an increase of 1.7% compared to the previous year [1]. Earnings Projections - The consensus EPS estimate has been revised downward by 8.2% over the past 30 days, indicating a collective reassessment by analysts [2]. - Revisions to earnings projections are crucial for predicting investor behavior, as empirical studies show a strong correlation between earnings estimate trends and short-term stock performance [3]. Revenue Estimates - Analysts estimate 'Revenues- Sales and other operating revenue' will reach $84.12 billion, indicating a year-over-year change of +4.6% [5]. - 'Revenues- Income from equity affiliates' is projected at $1.17 billion, reflecting a decline of 36.4% from the previous year [5]. - 'Revenues- Sales and other operating revenue- Specialty Products' is expected to be $7.16 billion, showing a significant increase of +55% year over year [6]. - 'Revenues- Sales and other operating revenue- Energy Products' is forecasted to reach $63.39 billion, indicating a slight decline of -1.3% from the prior year [6]. - 'Revenues- Sales and other operating revenue- Upstream- Non-U.S.' is estimated at $3.24 billion, down by 8% year over year, while 'Upstream- United States' is expected to rise by 161% to $5.72 billion [7]. - 'Revenues- Sales and other operating revenue- Chemical Products- Non-U.S.' is projected at $3.67 billion, a change of +0.6%, and 'Specialty Products- Non-U.S.' is expected to reach $5.31 billion, reflecting a +68.5% increase [8]. Production Estimates - Analysts project 'Oil-equivalent production per day' to be 4,584.05 KBOE/D, up from 3,784 KBOE/D in the same quarter last year [9]. - 'Natural gas production available for sale per day - Worldwide' is expected to reach 8,462.62 Mcf/D, compared to 7,362 Mcf/D a year ago [9]. - 'Net production of crude oil, natural gas liquids, bitumen and synthetic oil per day - Worldwide' is estimated at 3,139.27 thousand barrels, up from 2,557 thousand barrels in the same quarter last year [10]. - For the United States, 'Net production of crude oil, natural gas liquids, bitumen and synthetic oil per day' is projected at 1,395.05 thousand barrels, compared to 816 thousand barrels a year ago [11]. Stock Performance - Over the past month, Exxon shares have declined by 9%, while the Zacks S&P 500 composite has seen a minor decrease of 0.2% [12].